Literature DB >> 9590426

Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis.

E W Holmes1, S L Yong, D Eiznhamer, A Keshavarzian.   

Abstract

Oxidative stress appears to play a role in the tissue damage of active ulcerative colitis, and it has been suggested that a defect in mucosal antioxidant defenses is a etiological factor in the disease. This study was undertaken to investigate the mucosal content and oxidation state of glutathione in ulcerative colitis in the active and inactive states and to examine the relationship between glutathione content and disease activity in this patient population. Endoscopic biopsies of colon mucosa were collected from normal subjects, from macroscopically normal tissue of patients with inactive and active ulcerative colitis, and from inflamed tissue of patients with active ulcerative colitis. The mucosal contents of GSH and GSSG were determined by liquid chromatography. We found no significant differences in tissue contents of reduced glutathione among the four groups. The median tissue level of oxidized glutathione in inflamed mucosa from patients with active ulcerative colitis was increased 1.7-fold (P = 0.017) over that of patients with inactive disease. The oxidized glutathione content of the mucosa also showed significant positive correlations with clinical and histological indices of disease severity among ulcerative colitis patients. In conclusion, a change in the redox status of mucosal glutathione is associated with inflammation and disease activity in ulcerative colitis. This change appears to be a consequence of inflammation rather than a pathogenic factor for the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590426     DOI: 10.1023/a:1018899222258

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection. A selective review.

Authors:  H W Verspaget; T P Mulder; A van der Sluys Veer; A S Peña; C B Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  1991

2.  High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives.

Authors:  M W Fariss; D J Reed
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  High-affinity transport of glutathione is part of a multicomponent system essential for mitochondrial function.

Authors:  J Mårtensson; J C Lai; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Inflammatory bowel disease--a radical view.

Authors:  N J Simmonds; D S Rampton
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

5.  Oxidant defense mechanisms in the human colon.

Authors:  M B Grisham; R P MacDermott; E A Deitch
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

6.  Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.

Authors:  S Sedghi; J Z Fields; M Klamut; G Urban; M Durkin; D Winship; D Fretland; M Olyaee; A Keshavarzian
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

7.  Glutathione metabolism in Crohn's disease.

Authors:  T Iantomasi; P Marraccini; F Favilli; M T Vincenzini; P Ferretti; F Tonelli
Journal:  Biochem Med Metab Biol       Date:  1994-12

8.  Renal and hepatic output of glutathione in plasma and whole blood.

Authors:  P D Dass; E W Bermes; E W Holmes
Journal:  Biochim Biophys Acta       Date:  1992-12-08

9.  Regional variations in total and nonprotein sulfhydryl compounds in the human gastric mucosa and effects of ethanol.

Authors:  C Loguercio; M Romano; M Di Sapio; G Nardi; D Taranto; A Grella; C Del Vecchio Blanco
Journal:  Scand J Gastroenterol       Date:  1991-10       Impact factor: 2.423

10.  Apparent rates of glutathione turnover in rat tissues.

Authors:  D W Potter; T B Tran
Journal:  Toxicol Appl Pharmacol       Date:  1993-06       Impact factor: 4.219

View more
  28 in total

1.  Total antioxidant capacity of colon in patients with chronic ulcerative colitis.

Authors:  T R Koch; L X Yuan; S J Stryker; P Ratliff; G L Telford; E C Opara
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.

Authors:  Hala E Hamouda; Soha S Zakaria; Saber A Ismail; Mahmoud A Khedr; Wael W Mayah
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

3.  Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.

Authors:  A Keshavarzian; A Banan; A Farhadi; S Komanduri; E Mutlu; Y Zhang; J Z Fields
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 4.  Redox biology of the intestine.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Free Radic Res       Date:  2011-09-05

5.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

Review 6.  Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis.

Authors:  Sigrun Thorsteinsdottir; Thorkell Gudjonsson; Ole Haagen Nielsen; Ben Vainer; Jakob Benedict Seidelin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

Review 7.  Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?

Authors:  Ali Rezaie; Robyn D Parker; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

8.  Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.

Authors:  Mary P Bronner; Jacintha N O'Sullivan; Peter S Rabinovitch; David A Crispin; Lu Chen; Mary J Emond; Cyrus E Rubin; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

9.  Hydrogen peroxide inhibits Ca2+-dependent chloride secretion across colonic epithelial cells via distinct kinase signaling pathways and ion transport proteins.

Authors:  Alfred E Chappell; Michael Bunz; Eric Smoll; Hui Dong; Christian Lytle; Kim E Barrett; Declan F McCole
Journal:  FASEB J       Date:  2008-01-22       Impact factor: 5.191

10.  DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.

Authors:  Ru Chen; Peter S Rabinovitch; David A Crispin; Mary J Emond; Kent M Koprowicz; Mary P Bronner; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.